France halts Valneva’s chikungunya vaccine use in seniors
French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after serious…
Infectious Diseases
-
-
WHO member states agree on treaty to fight future pandemics
Member states of the World Health Organization (WHO) have reached an agreement on how to tackle future pandemics courtesy of…
-
ESCMID Global 2025: Climate-informed infectious disease risk management
At the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria, the development of…
-
FDA approves Bavarian Nordic’s freeze-dried mpox and smallpox vaccine
The US Food and Drug Administration (FDA) has approved the freeze-dried formulation of Bavarian Nordic’s smallpox and mpox vaccine in…
-
GSK and UK researchers plan to study Shingrix and dementia risk reduction link
GSK is collaborating with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to investigate…
-
UKHSA unveils high-risk pathogen list to drive innovation
The UK Health and Security Agency (UKHSA) has released a new watch list of 24 infectious diseases that could pose…
-
Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge
Valneva will provide 40,000 doses of its chikungunya vaccine Ixchiq to French overseas territory La Réunion as part of efforts…
-
Rising Sirturo resistance highlights urgent need for new TB therapies
There have been widespread reports that more effort and funding is needed to combat the TB crisis. As more cases…
-
Global funding cuts reversing decades of tuberculosis progress, WHO says
Ahead of World Tuberculosis Day on 24 March, the World Health Organization (WHO) has said that cuts in global funding…
-
Curevo procures $110m and former-GSK exec for shingles vaccine candidate
Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive…
